Jonathan Andrus, Chief Strategy Officer at Clinical Ink, shared his vision for the future of clinical trials in this #BeTheComeback video. Clinical Ink has been building towards solutions and technologies that support decentralized clinical trials all along. Direct data capture is a key aspect of being a catalyst for the Comeback.
